Lakefront Biotherapeutics N.V.
- LKFT
- NASDAQ
- Biotechnology
- Small Molecule Drugs
- Antibody Therapeutics
$29.79
Today −0.37%Quote Oct 19, 2026, 08:00 PM UTC
+4.34%over the last month
Max drawdown −6.1%From 1-month high −3.0%3 months +1.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Lakefront Biotherapeutics
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
452
Market value
$1.95B
Quote Oct 19
Floor
$29.53
0.9% below price
Resistance
$30.05
0.9% above price
Price vs analyst targets
2 analysts
Lowest target
$26.00Highest target
$45.00
$26.00Highest target
$45.00
- Price $29.79
- Average target $35.50
- Analysts' target range
Analysts' average target sits about 19% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LKFTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free